HEPATOCELLULAR CANCER
Clinical trials for HEPATOCELLULAR CANCER explained in plain language.
Never miss a new study
Get alerted when new HEPATOCELLULAR CANCER trials appear
Sign up with your email to follow new studies for HEPATOCELLULAR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Drug attack on tough cancers shows early promise
Disease control CompletedThis early-stage study tested the safety of combining two experimental drugs, vobramitamab duocarmazine and lorigerlimab, in people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to find a safe dose and see how the body processes …
Matched conditions: HEPATOCELLULAR CANCER
Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Doctors track side effects of liver cancer drug in Real-World patients
Disease control CompletedThis study monitored the safety of the cancer drug Cabometyx (cabozantinib) in 263 Japanese patients with advanced liver cancer that could not be removed by surgery. The main goal was to check for side effects and serious health problems over 12 months of treatment. Doctors also …
Matched conditions: HEPATOCELLULAR CANCER
Sponsor: Takeda • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Malaria drug added to cancer therapy in bid to halt liver tumor growth
Disease control CompletedThis study tested whether adding the drug hydroxychloroquine (HCQ) to the standard liver cancer drug sorafenib could better control advanced liver cancer. It involved 64 patients with cancer not eligible for surgery or transplant. Researchers aimed to see if the drug combination …
Matched conditions: HEPATOCELLULAR CANCER
Phase: PHASE2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Mar 09, 2026 14:27 UTC
-
Pre-Surgery pill tested to ease pain after liver procedure
Symptom relief CompletedThis study tested if giving a medication called pregabalin before a liver cancer treatment could help reduce pain afterwards. It involved 70 patients with liver cancer who were scheduled for a procedure called radiofrequency ablation. The goal was to see if this approach improved…
Matched conditions: HEPATOCELLULAR CANCER
Phase: PHASE4 • Sponsor: Sherief Abd-Elsalam • Aim: Symptom relief
Last updated Mar 30, 2026 14:30 UTC